LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Immunologic overlap in a case of linear IgG/IgA bullous dermatosis responsive to rituximab

Photo from wikipedia

BP: bullous pemphigoid LABD: linear IgA bullous dermatosis LAGBD: linear IgA/IgG bullous dermatosis INTRODUCTION Autoimmune subepidermal blistering diseases are caused by immunological loss of tolerance to components of hemidesmosomes, triggering… Click to show full abstract

BP: bullous pemphigoid LABD: linear IgA bullous dermatosis LAGBD: linear IgA/IgG bullous dermatosis INTRODUCTION Autoimmune subepidermal blistering diseases are caused by immunological loss of tolerance to components of hemidesmosomes, triggering humoral and cellular responses. C3 and IgG deposition along the basement membrane zone is characteristic of bullous pemphigoid (BP). Alternately, IgA deposition at the basement membrane zone is consistent with linear IgA bullous dermatosis (LABD). An immunological overlap spanning the clinical and immunologic spectrum between BP and LABD has been reported and referred to as linear IgA/IgG bullous dermatosis (LAGBD). LAGBD has a unique clinical presentation, immunologic properties, and distinct therapeutic options including rituximab.

Keywords: rituximab; iga bullous; immunologic; bullous dermatosis; linear iga; dermatosis

Journal Title: JAAD Case Reports
Year Published: 2021

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.